Big Picture Bio
Big Picture Bio builds a cancer research model that predicts which drug combinations may work together, helping biopharma teams prioritize therapies and experiments.
£2.2MPre-seed and Innovate UK grant package
LeadKC
Kadmos Capital
Activity from announced rounds
Activity in this selectionOct 11, 2026 · Europe · Jan 1, 2026
- Rounds participated in
- 4
- Confirmed lead rounds
- 1 1 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $15.6M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionAeon
Preventive health check-ups that combine whole-body MRI, blood biomarkers and medical interpretation to give people a broader view of their health risks.
UndisclosedSeed extension
ParticipantAntiverse
Antiverse designs therapeutic antibodies for difficult drug targets using generative AI, engineered cell lines and in-house laboratory testing.
$9.3MSeries A
ParticipantOutSee
Develops AI-based predictive genomics approach to target discovery
£2.5MSeed
Role not disclosed